16:01 Dec 05

Coral Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
463.40
-6.35 (-1.35%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Coral Laboratories Ltd. Financials

Coral Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
463.40
-6.35 (-1.35%)
16:01 Dec 05
Quality
image/svg+xml

64/100
High Financial Strength

Valuation
image/svg+xml

39/100
Mid Valuation

Technical

30/100
Technically Bearish

Strength

12

Weakness

9

Opportunity

0

Threats

0

12.00 %

ROE %

10.52 %

ROA %

0.00

EPS

563.19

BVPS

0.00 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
75.61 78.12 83.66 115.01 102.17
Operating Expenses +
67.4 74.31 67.42 88.76 84.47
Raw Material
39 42.11 40.38 49.7 46.35
Increase Decrease in Cost
0.71 3.64 -3.13 3.32 1.97
Other Manufacturing Expense
2.74 3.33 2.89 3.32 0
Employee Cost
11.23 11.13 11.2 14.74 14.56
Miscellaneous Expenses
14.98 15.52 17.48 20.8 21.59
Operating Profit
8.21 3.81 16.24 26.25 17.7
Other Income
4.81 6.9 6.63 9.11 9.59
Depreciation
1.99 2.18 1.98 2.01 1.97
Interest
0.14 0.34 0 0.1 0.13
Profit before tax and exceptio..
10.9 8.19 20.9 33.24 25.19
Exceptional Items
0.96 0.04 -0.16 -0.77 -0.77
PBT
11.86 8.23 20.73 32.47 25.96
Provision for Taxation
2.81 1.78 4.94 8.31 6.5
Net Profit
9.05 6.45 15.79 24.16 17.91
NET Profit after MI
0 0 0 0 0
EPS
25.32 18.04 44.19 67.61 50.15
Operating Profit Margin (%)
10.86 4.88 19.41 22.82 17.32
Net Profit Margin (%)
11.97 8.26 18.87 21.01 17.53

Coral Laboratories Ltd. Shareholding

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 71.50 71.50 71.50 71.50 71.50 71.50
FII 0.00 0.00 0.00 0.00 0.00 0.20
Public 0.00 0.00 0.00 0.00 0.00 0.00
Others 28.50 28.50 28.50 28.50 28.50 28.30
Shareholder Shares Holding %
Download Our App On: